UK: Cytyc's Novasure awaits NICE (National Institute for Clinical Excellence) verdict
This article was originally published in Clinica
Cytyc has launched its Novasure radiofrequency endometrial ablation system in the UK, as part of plans to expand its EU market coverage of the technology. The impedance-controlled bipolar ablation system used to treat menorrhagia (heavy menstrual bleeding) was CE-marked in 2002, but Novasure's real success in the UK is set to hinge on the current assessment of the technology by the National Institute for Clinical Excellence (NICE).
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.